EntryPoint Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$726K Hold
1,876
0.18% 170
2026
Q1
$549K Buy
+1,876
New +$617K 0.16% 214
2025
Q4
Sell
-990
Closed -$320K 715
2025
Q3
$320K Buy
+990
New +$308K 0.12% 341

Other funds holding ELV

EntryPoint Capital's ELV Position: Q2 2026 in Review

EntryPoint Capital held its Elevance Health (ELV) position steady in Q2 2026 at 1,876 shares worth $726K. The position accounts for 0.18% of the portfolio, ranked #170.

EntryPoint Capital first reported a position in ELV in Q3 2025 and has held it in 3 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • EntryPoint Capital held 1,876 shares of Elevance Health worth $726K as of Q2 2026.
  • EntryPoint Capital left its Elevance Health share count unchanged in Q2 2026.
  • Elevance Health made up 0.18% of EntryPoint Capital's portfolio in Q2 2026, its #170 holding.
  • EntryPoint Capital first reported a position in Elevance Health in Q3 2025 and has held it in 3 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on EntryPoint Capital's 13F filing for Q2 2026, filed 13 Aug 2026.